Trial Profile
Rectal preserving treatment for early rectal cancer. A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancers.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- 27 Oct 2015 New trial record